Search Results - L. Musick

7 | POLATUZUMAB VEDOTIN, RITUXIMAB, GEMCITABINE AND OXALIPLATIN (POLA‐R‐GEMOX) FOR RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): PHASE III POLARGO TRIAL Autoría: J. Sancho, Z. Li, T. P. Vassilakopoulos, A. Viardot, A. McMillan, M. Sinan Dal, J. Pereira, J. S. Kim, L. Qiu, C. L. Batlevi, R. Ibrahim, J. Hernandez, B. McCall, Y. Jiang, M. Yan, W. Harris, L. Musick, C. Haioun, M. Matasar